Publications by authors named "Lina Marcela Cruz Hernandez"
Integrating clinical research in an operative screening and diagnostic breast imaging department: First experience, results and perspectives using microwave imaging.
Heliyon
November 2023
Article Synopsis
- Clinical research is essential for evaluating new medical techniques, particularly in breast imaging, as demonstrated by the introduction of microwave breast imaging (MBI) using the MammoWave apparatus in a multicentric study.
- The study involved 180 volunteers, who underwent both conventional imaging and MBI, with results showing that MBI had a detection sensitivity of 85.8% for breast lesions, ultimately confirming its effectiveness in identifying cancers.
- The successful implementation of an optimal recruitment strategy indicates the potential for microwave imaging to become an important tool in breast screening, with future trials expected to further validate its clinical usefulness.
Dielectric characterization has significant potential in several medical applications, providing valuable insights into the electromagnetic properties of biological tissues for disease diagnosis, treatment planning, and monitoring of therapeutic interventions. This work presents the use of a custom-designed electromagnetic characterization system, based on an open-ended coaxial probe, for discriminating between benign and malignant breast tissues in a clinical setting. The probe's development involved a well-balanced compromise between physical feasibility and its combined use with a reconstruction algorithm known as the virtual transmission line model (VTLM).
View Article and Find Full Text PDFDiagnostic value of halo sign in young women (aged 45 to 49 years) in a breast screening programme with synthesized 2D mammography.
Br J Radiol
December 2018
Objective:: To assess the clinical performance of the halo sign in tomosynthesis and synthesized 2D mammography, and to identify age groups where its diagnostic value may be greater.
Methods:: 183 patients with nodules were recalled from the breast screening programme (with tomosynthesis and 2D synthesized mammograms). The patients were separated into two groups, 45-49 years and 50-69 years, and depending on the presence or not of halo sign.